Inaugural Immunometabolism and Chronic Diseases Conference

  • null
    Douglas Green (Keynote Speaker)
    St. Jude Children's Research Hospital, Memphis
  • null
    Ruslan Medzhitov (Keynote Speaker)
    Howard Hughes Medical Institute / School of Medicine, Yale University, Connecticut
  • null
    Maxim Artyomov
    Washington University, St Louis, USA
  • null
    Steve Besinger
    David Geffen School of Medicine, UCLA, Los Angeles, USA
  • null
    Navdeep Chandel
    Feinberg School of Medicine, Northwestern University, Chicago USA
  • null
    Heather Christofk
    David Geffen School of Medicine,  UCLA, Los Angeles, USA
  • null
    Vishwa Deep Dixit
    Yale School of Medicine, New Haven, Connecticut, USA
  • null
    Vishwa M Dixit
    Genentech, Inc, New York, USA
  • null
    Eicke Latz
    Institute of Innate Immunity, University of Bonn, Germany
  • null
    Lydia Lynch
    Harvard Medical School, Boston, USA
  • null
    Seth Masters
    Walter and Eliza Hall Institute of Medical Research, Melbourne.Australia
  • null
    Luke O’Neill
    Trinity Biomedical Sciences Institute: Trinity College, Dublin, Ireland
  • null
    Erika Pearce
    Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany
  • null
    Kate Schroder
    Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia
  • null
    Janelle Ayres
    Salk Institute for biological studies, La Jolla, USA
  • null
    Susan Kaech
    Yale University, New York, USA
  • null
    Dan Littman
    Howard Hughes Medical Institute / Skirball Institute of Biomolecular Medicine of New York University, New York, USA
  • null
    Brendan Manning
    Harvard University’s T.H. Chan School of Public Health, Boston, USA
  • null
    Christian Metallo
    University of California, San Diego, USA
  • null
    Ralph DeBerardinis
    The Children’s Medical Center Research Institute (CRI), University of Texas Southwestern Medical Center, Dallas, USA
  • null
    Russell Jones
    Goodman Cancer Research Centre at McGill University, Montreal, Canada
  • null
    Michael Karin
    University of California, San Diego, USA
  • null
    Reuben Shaw 
    Salk Institute for Biological Studies, La Jolla, USA
  • null
    Erwin Wagner
    CNIO, Madrid, Spain
  • null
    Xiaodong Wang
    National Institute of Biological Sciences, Beijing, China
  • null
    Marc Donath
    University of Basel, Switzerland
  • null
    Mark Febbraio
    Garvan Institute of Medical Research, Sydney, Australia
  • null
    Edward Pearce
    Max Planck Institute for Immunobiology and Epigenetics, Freiburg, Germany
  • null
    Alyssa Hasty
    School of Medicine, Vanderbilt University, Nashville, USA
  • null
    Andrea Hevener
    David Geffen School of Medicine, UCLA, Los Angeles, USA
  • null
    Takashi Kadowaki
    School of Medicine, University of Tokyo, Japan
  • null
    Diane Matthis
    Harvard Medical School, Boston, USA
  • null
    Philipp Scherer
    Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, USA
  • null
    Steve Shoelson
    Harvard Medical School, Boston, USA
  • null
    Carolin Daniel
    -
  • null
    Andrew Pospisilik
    -


Chronic diseases associated with immunometabolic dysfunction are growing exponentially in all parts of the world. However, in the Asia Pacific Region the growth of some of these diseases is alarming. 

For example, countries in this region have the highest rates of obesity, type 2 diabetes and liver diseases worldwide, but the region is largely overlooked when global health problems associated with chronic diseases are assessed. 

Conference Objectives

It is a major goal of this meeting to highlight the importance of cutting edge research in this field in order to develop better treatments and to decrease the social and economic burden of chronic disease in the Asia Pacific Region.  It is also to provide attendees with a comprehensive overview of current research on chronic diseases with a focus on the latest developments in the immunometabolic mechanisms that contribute to disease initiation and progression.

This is the inaugural conference that will bring together high level scientists from different disciplines and participants from all career levels. The format of the meeting will encourage thorough discussions of the latest research in the field between established and young investigators and trainees, along with cross-fertilisation among scientists from a variety of backgrounds.

 

Registrations are open!!

*Registrations are dependent on the aviability of the accommodation. Contact us for more information. 

Key Sessions

  1. ImmunoMetabolism I
  2. Obesity Inflammation & Cancer
  3. Adipose Tissue Inflammation & Metabolic Disease
  4. Innate Immunity & Inflammasomes
  5. Microbiome and adaptive immunity
  6. Cancer Metabolism
  7. Immune Cell Signaling, Cytokines & Metabolic Reprogramming
  8. ImmunoMetabolism II
  9. Obesity, Inflammation & Metabolism

Who Should Attend

We encourage young scientists/clinicians to attend and expect broad representation from various disciplines. The conference will especially appeal to scientists, scientists/clinicians in academia, biotech and pharmaceutical companies with interest in Biology, Immunology, Metabolic Diseases, Immuno-Metabolism, Molecular/Cellular Biology and Epigenetics.

Site by MooballIT

Personal tools